Delivery Order SPE2DB22D9207-SPE2DB25FH4WV

Award Date 2/20/25
Potential Completion Date 2/21/25
Potential Value $2.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,436.40 contract covers the delivery of 4,567,133,666 units of Fexofenadine HCL 180 mg tablets to support the medical supply needs of military healthcare facilities. The contract is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,580.64, is for the supply of 4565945539 - Fexofenadine HCL 180 mg Tablets in 500-count packages. This order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and DLA under the SPE2DB program, with a potential value of up...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,436.40 contract covers the delivery of 500 tablets of fexofenadine hydrochloride 180 mg to support the medical supply needs of military healthcare facilities. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This...
This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The award is a delivery order valued at $1,903.78 for the provision of Fexofenadine HCL 180 mg tablets. The contract is a firm fixed-price delivery order that does not have a set-aside designation. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $2,154.60, is a firm fixed-price delivery order for the supply of 4567387654 ! FEXOFENADINE HCL 180 MG TABLET 500S, a prescription medication. The contract has an ultimate completion date of February 24, 2025. DMS Pharmaceutical Group Inc. also holds a larger Indefinite...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois, is a delivery order valued at $2,460.12 issued by the Defense Logistics Agency (DLA). The contract is for the delivery of 4,567,324,784 tablets of the pharmaceutical drug Fexofenadine HCL 180 mg and has a completion date of January 31, 2025. The contract is not associated with any set-aside designation. It is part of a larger $499,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a delivery order valued at $1,571.95 under the Defense Logistics Agency's (DLA) SPE2DB program. The contract is for the delivery of 4,561,591,012 units of fexofenadine HCl 180 mg tablets to support the recurring pharmaceutical supply needs of military health facilities worldwide. The SPE2DB program is a single-award indefinite delivery contract (IDC) valued up to...
This is a Firm Fixed Price delivery order contract awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,479.47 award was issued by the Defense Logistics Agency's (DLA) Medical Supply Chain division to provide a variety of pharmaceutical products to support military health facilities. The delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical...
This is a firm fixed-price delivery order contract awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA) under the Medical Supply Chain program. The contract, valued at $1,701.70, is for the delivery of a variety of pharmaceutical products to support the recurring medical supply needs of military health facilities worldwide. The products include medications such as flumazenil injections, prednisone tablets,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order, worth $97,580.10, is for the supply of a variety of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military healthcare facilities. This...
  • SPE2DB22D9207
    Indefinite Delivery Contract
  • SPE2DB22D9207-SPE2DB25FH4WV
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $2,872.80, is for the delivery of 4,567,372,728 units of Fexofenadine HCL 180 mg tablets by February 21, 2025.

DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide. The current delivery order is not associated with a set-aside designation, which enables DMS Pharmaceutical Group to leverage its woman-owned small business status to secure direct federal awards across multiple product categories and medical domains.

Generated 5/22/25, 8:19 PM